Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingre Jiedu Mixture for pediatric viral encephalitis and meningitis
ChiCTR1900023274Phase 4Not yet recruiting
- Sponsor
- Beijing Ditan Hospital
- Start
- Jan 2017
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Qingre Jiedu Mixture in viral encephalitis and viral meningitis (VM) (2 arms), sponsored by Beijing Ditan Hospital. Primary endpoint: Cure rate. Planned start Jan 2017; status: not yet recruiting.
02
Drugs
Qingre Jiedu Mixture
03
Conditions
viral encephalitisviral meningitis (VM)
Beyond the preview
Go deeper on ChiCTR1900023274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023274.